Walter M. Cronin

11.9k total citations · 4 hit papers
31 papers, 8.5k citations indexed

About

Walter M. Cronin is a scholar working on Cancer Research, Genetics and Oncology. According to data from OpenAlex, Walter M. Cronin has authored 31 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 16 papers in Genetics and 14 papers in Oncology. Recurrent topics in Walter M. Cronin's work include Breast Cancer Treatment Studies (15 papers), Estrogen and related hormone effects (14 papers) and Cancer Risks and Factors (8 papers). Walter M. Cronin is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Estrogen and related hormone effects (14 papers) and Cancer Risks and Factors (8 papers). Walter M. Cronin collaborates with scholars based in United States and Canada. Walter M. Cronin's co-authors include D. Lawrence Wickerham, Joseph P. Costantino, Carol Redmond, Norman Wolmark, Bernard Fisher, Leslie G. Ford, André Robidoux, James N. Atkins, Maureen Kavanah and Victor G. Vogel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Walter M. Cronin

31 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 4.0k citations Bernard Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute profile →
Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

1995 1.1k citations Bernard Fisher, Carol Redmond et al. profile →
Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

1994 959 citations B. Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute profile →
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2005 937 citations Bernard Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Walter M. Cronin

Since Specialization

Citations

This map shows the geographic impact of Walter M. Cronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter M. Cronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter M. Cronin more than expected).

Fields of papers citing papers by Walter M. Cronin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter M. Cronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter M. Cronin. The network helps show where Walter M. Cronin may publish in the future.

Co-authorship network of co-authors of Walter M. Cronin

This figure shows the co-authorship network connecting the top 25 collaborators of Walter M. Cronin. A scholar is included among the top collaborators of Walter M. Cronin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter M. Cronin. Walter M. Cronin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey 2018 ·Contemporary Clinical Trials Communications ·Elise D. Cook, Katherine A. Yeager, Reena S. Cecchini, (unknown), Carol L. Brown, (unknown), Walter M. Cronin, Electra D. Paskett	10
2	The Globalization of Cooperative Groups 2015 ·Seminars in Oncology ·Manuel Valdivieso, Benjamin W. Corn, Janet Dancey, D. Lawrence Wickerham, Laura E. Horvath, Edith A. Perez, (unknown), Walter M. Cronin, Erica Field, (unknown), Charles D. Blanke	5
3	Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer. 2015 ·Journal of Clinical Oncology ·D. Lawrence Wickerham, Reena S. Cecchini, Victor G. Vogel, Joseph P. Costantino, Walter M. Cronin, Therese B. Bevers, Louis Fehrenbacher, Eduardo R. Pajon, James L. Wade, André Robidoux, Richard G. Margolese, Joan James, Carolyn D. Runowicz, Patricia A. Ganz, Steven E. Reís, Worta J. McCaskill-Stevens, Leslie G. Ford, V. Craig Jordan, Norman Wolmark	9
4	Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials 2012 ·Cancer Prevention Research ·Reena S. Cecchini, Joseph P. Costantino, Jane A. Cauley, Walter M. Cronin, D. Lawrence Wickerham, Stephanie R. Land, Joel L. Weissfeld, Norman Wolmark	92
5	Baseline Mammographic Breast Density and the Risk of Invasive Breast Cancer in Postmenopausal Women Participating in the NSABP Study of Tamoxifen and Raloxifene (STAR) 2012 ·Cancer Prevention Research ·Reena S. Cecchini, Joseph P. Costantino, Jane A. Cauley, Walter M. Cronin, D. Lawrence Wickerham, Hanna Bandos, Joel L. Weissfeld, Norman Wolmark	21
6	Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups 2011 ·Clinical Cancer Research ·Anneke T. Schroen, Gina R. Petroni, Hongkun Wang, (unknown), Robert J. Gray, Jacqueline Benedetti, Xiaofei F. Wang, Daniel J. Sargent, D. Lawrence Wickerham, Walter M. Cronin, Benjamin Djulbegović, Craig L. Slingluff	52
7	Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR) 2011 ·American Journal of Obstetrics and Gynecology ·Carolyn D. Runowicz, Joseph P. Costantino, D. Lawrence Wickerham, Reena S. Cecchini, Walter M. Cronin, Leslie G. Ford, Victor G. Vogel, Norman Wolmark	37
8	Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer 2010 ·Cancer Prevention Research ·Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Reena S. Cecchini, James N. Atkins, Therese B. Bevers, Louis Fehrenbacher, Eduardo R. Pajon, James L. Wade, André Robidoux, Richard G. Margolese, Joan James, Carolyn D. Runowicz, Patricia A. Ganz, Steven E. Reís, Worta McCaskill‐Stevens, Leslie G. Ford, V. Craig Jordan, Norman Wolmark, (unknown)	438
9	The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer 2008 ·Recent results in cancer research ·D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Walter M. Cronin, Reena S. Cecchini, Leslie G. Ford, Norman Wolmark	29
10	The Half Century of Clinical Trials of the National Surgical Adjuvant Breast and Bowel Project 2008 ·Seminars in Oncology ·D. Lawrence Wickerham, Michael J. O’Connell, Joseph P. Costantino, Walter M. Cronin, Soonmyung Paik, Charles E. Geyer, Patricia A. Ganz, Nicholas J. Petrelli, Eleftherios P. Mamounas, Thomas B. Julian, Norman Wolmark	15
11	NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor—Positive Breast Cancer 2006 ·Clinical Breast Cancer ·Eleftherios P. Mamounas, Barry C. Lembersky, Jong‐Hyeon Jeong, Walter M. Cronin, (unknown), Charles E. Geyer, D. Lawrence Wickerham, Soonmyung Paik, Joseph P. Costantino, Norman Wolmark	33
12	Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study breakdown → 2005 ·JNCI Journal of the National Cancer Institute ·Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Reena S. Cecchini, Walter M. Cronin, André Robidoux, Therese B. Bevers, Maureen Kavanah, James N. Atkins, Richard G. Margolese, Carolyn D. Runowicz, Joan James, Leslie G. Ford, Norman Wolmark	937
13	Contralateral Breast Cancer and Thromboembolic Events in African American Women Treated With Tamoxifen 2004 ·JNCI Journal of the National Cancer Institute ·Worta McCaskill‐Stevens, John Wilson, John Bryant, E. Mamounas, Lucy Garvey, Joan James, Walter M. Cronin, D. L. Wickerham	20
14	Skin rash and good performance status (PS) predict improved survival with gefitinib for patients with advanced non-small cell lung cancer (NSCLC) 2004 ·Journal of Clinical Oncology ·Mahfuzah Mohamed, Suresh S. Ramalingam, Yan Lin, William E. Gooding, Walter M. Cronin, John R. Eckardt, Chandra P. Belani	10
15	National Surgical Adjuvant Breast and Bowel Project Update 2003 ·Clinical Cancer Research ·Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin	1
16	The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data from a Randomized Breast Cancer Risk Reduction Trial 2002 ·Clinical Breast Cancer ·Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Norman Wolmark	64
17	Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study 1999 ·Journal of Clinical Oncology ·Richard Day, Peter Ganz, Joseph P. Costantino, Walter M. Cronin, D. Lawrence Wickerham, Bernard Fisher	337
18	Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study breakdown → 1998 ·JNCI Journal of the National Cancer Institute ·Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, (unknown), (unknown)	4021
19	Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 * breakdown → 1994 ·JNCI Journal of the National Cancer Institute ·B. Fisher, Joseph P. Costantino, Carol Redmond, E R Fisher, D. Lawrence Wickerham, Walter M. Cronin, (unknown)	959
20	The efficacy of bone scanning in the follow-up of patients with operable breast cancer 1984 ·Breast Cancer Research and Treatment ·Lawrence Wickerham, (unknown), Walter M. Cronin, Leo L. Stolbach, Neil Abramson, David M. J. S. Bowman, Peter J. Deckers, Peter D. Eisenberg, Roger S. Foster, Andrew G. Glass, Saul Kay, (unknown), David Prager, Kathleen I. Pritchard	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact